Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166930 | SCV000217749 | likely benign | Hereditary cancer-predisposing syndrome | 2014-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Counsyl | RCV000410230 | SCV000488044 | likely benign | Li-Fraumeni syndrome 1 | 2015-12-16 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000166930 | SCV000911990 | likely benign | Hereditary cancer-predisposing syndrome | 2018-07-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000166930 | SCV002582532 | likely benign | Hereditary cancer-predisposing syndrome | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000410230 | SCV002582834 | likely benign | Li-Fraumeni syndrome 1 | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005089831 | SCV005833451 | likely benign | Li-Fraumeni syndrome | 2024-07-17 | criteria provided, single submitter | clinical testing |